Baidu
map

European Radiology:严重钙化的冠脉究竟要如何评估狭窄程度?CTA有了新办法!

2022-02-14 shaosai MedSci原创

冠状动脉计算机断层扫描(CCTA)是检测冠状动脉狭窄的首选无创影像学检查。然而,对于有严重钙化斑块的节段,CCTA的诊断准确性十分有限。

冠状动脉计算机断层扫描(CCTA)是检测冠状动脉狭窄的首选无创影像学检查。然而,对于有严重钙化斑块的节段,CCTA的诊断准确性十分有限

随着最近减影CCTA(CCTASub)的发展,通过从相应的对比后CT图像数据中减去非对比CT图像数据,可以将冠状动脉钙化从图像中去除。由于该技术需要额外的后处理和辐射暴露因此选择最适合接受CCTASub检查的病例十分重要。

然而目前还不清楚哪些病例能从CCTAsub中获益最大。严重钙化的斑块和非严重(轻度或中度)钙化的斑块会降低CCTA的诊断准确性。

近日,发表在European Radiology杂志的一项研究使用320排CT,以有无减影信息的传统CCTA(CCTACon+Sub vs CCTACon)作为参考标准,比较了该技术在非严重和严重钙化节段应用的诊断信心、准确性和观察者间的一致性,减影技术在临床上的进一步广泛应用提供了数据支持

2019年10月-2020年6月,本研究将64名疑似冠状动脉疾病(CAD)的患者(33名男性,66.6±8.2岁)纳入评估。钙化的横断面弧度被用来将钙化节段分为非严重( < 180°) 或严重钙化( ≥ 180°)。三位独立的放射学家评估了冠状动脉狭窄的严重程度。使用Fleiss'kappa (κ)评估观察者间的一致性。采用多读者多案例的受试者工作特征(ROC)方法,用ROC曲线下的平均面积(AUC)衡量诊断准确性,以≥50%的狭窄为分界点。在严重和非严重钙化的节段,比较了有无减影信息的CCTA的诊断信心、诊断准确性和观察者间的一致性。 

在严重钙化的病例中(51名患者,146个节段),有减影信息的CCTA取得了更好的诊断准确性(每个患者AUC。0.73 vs 0.57,p = 0.03;每节段AUC。0.85 vs 0.62, p = 0.01)、诊断置信度(3.7 vs 2.6, p < 0.001),以及观察者之间的一致性(κ:0.59 vs 0.30)。诊断准确性(每个病人的AUC。0.81 vs 0.93, p = 0.30;每个病人的AUC。0.79 vs 0.82, p = 0.54)在非严重钙化的病例中没有增加(13名患者,190个节段)。 

 法CCTA对有严重钙化(钙化截面弧度≥180°)节段显示。左前降支中段的轴位(a)和CPR(c)图像,CCTACon上有严重的钙负荷。CCTASub的轴(b)和CPR(d)图像。ICA图像(e)。箭头表示钙化斑块,有无钙质减影,ICA上有相同病变。

 

本研究表明CCTACon+Sub技术可增加严重钙化病变的诊断可信度、准确性和观察者间的一致性,这为该类患者的病情准确评估提供了有价值的参考依据

 

原文出处

Lixue Xu,Fang Li,Kewei Wu,et al.Subtraction improves the accuracy of coronary CT angiography for detecting obstructive disease in severely calcified segments.DOI:10.1007/s00330-021-08092-5

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1729352, encodeId=b1a21e29352cc, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 21 08:44:15 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199923, encodeId=3cf611999238a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bad92496760, createdName=1248d98dm91暂无昵称, createdTime=Sun Mar 06 15:53:22 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1850148, encodeId=1d771850148c0, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Apr 17 05:44:15 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195152, encodeId=bd3811951526f, content=时刻关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=杨海东, createdTime=Sat Feb 19 20:26:50 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193370, encodeId=899b11933e0ea, content=Lihail , beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211219/4fb680a29895401b956ae66386b2c4d6/06dcda69473e49eb8c54e2e5bd9347c0.jpg, createdBy=35416411875, createdName=阿兹卡班在逃摄魂怪, createdTime=Mon Feb 14 17:54:45 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-02-21 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1729352, encodeId=b1a21e29352cc, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 21 08:44:15 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199923, encodeId=3cf611999238a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bad92496760, createdName=1248d98dm91暂无昵称, createdTime=Sun Mar 06 15:53:22 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1850148, encodeId=1d771850148c0, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Apr 17 05:44:15 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195152, encodeId=bd3811951526f, content=时刻关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=杨海东, createdTime=Sat Feb 19 20:26:50 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193370, encodeId=899b11933e0ea, content=Lihail , beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211219/4fb680a29895401b956ae66386b2c4d6/06dcda69473e49eb8c54e2e5bd9347c0.jpg, createdBy=35416411875, createdName=阿兹卡班在逃摄魂怪, createdTime=Mon Feb 14 17:54:45 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-03-06 1248d98dm91暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1729352, encodeId=b1a21e29352cc, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 21 08:44:15 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199923, encodeId=3cf611999238a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bad92496760, createdName=1248d98dm91暂无昵称, createdTime=Sun Mar 06 15:53:22 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1850148, encodeId=1d771850148c0, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Apr 17 05:44:15 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195152, encodeId=bd3811951526f, content=时刻关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=杨海东, createdTime=Sat Feb 19 20:26:50 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193370, encodeId=899b11933e0ea, content=Lihail , beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211219/4fb680a29895401b956ae66386b2c4d6/06dcda69473e49eb8c54e2e5bd9347c0.jpg, createdBy=35416411875, createdName=阿兹卡班在逃摄魂怪, createdTime=Mon Feb 14 17:54:45 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-04-17 windight
  4. [GetPortalCommentsPageByObjectIdResponse(id=1729352, encodeId=b1a21e29352cc, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 21 08:44:15 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199923, encodeId=3cf611999238a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bad92496760, createdName=1248d98dm91暂无昵称, createdTime=Sun Mar 06 15:53:22 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1850148, encodeId=1d771850148c0, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Apr 17 05:44:15 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195152, encodeId=bd3811951526f, content=时刻关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=杨海东, createdTime=Sat Feb 19 20:26:50 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193370, encodeId=899b11933e0ea, content=Lihail , beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211219/4fb680a29895401b956ae66386b2c4d6/06dcda69473e49eb8c54e2e5bd9347c0.jpg, createdBy=35416411875, createdName=阿兹卡班在逃摄魂怪, createdTime=Mon Feb 14 17:54:45 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-02-19 杨海东

    时刻关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1729352, encodeId=b1a21e29352cc, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 21 08:44:15 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199923, encodeId=3cf611999238a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bad92496760, createdName=1248d98dm91暂无昵称, createdTime=Sun Mar 06 15:53:22 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1850148, encodeId=1d771850148c0, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Apr 17 05:44:15 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195152, encodeId=bd3811951526f, content=时刻关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=杨海东, createdTime=Sat Feb 19 20:26:50 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193370, encodeId=899b11933e0ea, content=Lihail , beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211219/4fb680a29895401b956ae66386b2c4d6/06dcda69473e49eb8c54e2e5bd9347c0.jpg, createdBy=35416411875, createdName=阿兹卡班在逃摄魂怪, createdTime=Mon Feb 14 17:54:45 CST 2022, time=2022-02-14, status=1, ipAttribution=)]

相关资讯

陈韵岱:CCTA临床适用推荐及循证支持

作为诊断冠状动脉性心脏病的影像学工具,冠状动脉CT成像(CCTA)已经成为最主要的无创手段之一。尤其在当今“无影像,不干预”的时代背景下,CCTA的临床适应证也不断得到更新。大量文献显示CCTA诊断冠状动脉疾病的准确性极佳,可以评估有症状的中危冠心病患者的冠脉情况,这对于心内科医生的临床诊断流程和治疗相关路径又提出了新的要求。下面就CCTA在临床尤其对心内科常见病的适用标准及循证支持展开简要论

SCCT 2014:CCTA预测冠脉疾病患者生存或更佳

心血管CT学会(SCCT)2014年会的一项报告表明,与接受心肌单光子发射体层摄影(SPECT)检查的可疑冠脉疾病患者相比,冠状动脉CT血管造影(CCTA)检查者在随访期间生存率较高和无因心梗所致住院的可能性更大。 此项回顾性研究对25000例接受CCAT或心肌SPECT检查患者的资料进行了评估,并排除了同时接受CCAT和SPECT检查的患者。剩余患者分别有7376和4467例接受CCAT和SP

J Hepatol:非酒精性脂肪性肝病与亚临床冠状动脉粥样硬化之间的相关性

在无症状的个体中,非酒精性脂肪肝(NAFLD)是非钙化斑块的独立危险因子,被称为与突发和意外心脏事件相关的易损斑块。因此,NAFLD需要适当的药物治疗,以减少未来的心脏事件。

Baidu
map
Baidu
map
Baidu
map